| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.88 | 0.0002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |